Biodexa Pharmaceuticals Plc [BDRX] - IPO
Biodexa Pharmaceuticals Plc is set to offer Depositary Shares, with specific pricing and offering size details not disclosed in the filing excerpt.
Why this matters
Biodexa Pharmaceuticals Plc, formerly known as Midatech Pharma Plc, operates in the pharmaceutical preparations industry, focusing on developing treatments for serious conditions. The company has announced its intention to offer Depositary Shares, although specific details regarding the pricing and size of the offering are not provided in the available filing. Biodexa is advancing its pipeline with significant developments, such as the FDA's fast track designation for its drug eRapa, aimed at treating familial adenomatous polyposis (FAP), and the initiation of a Phase 3 clinical trial in the United States and Europe. The IPO comes as the company seeks to capitalize on these advancements and potentially fund further development activities.